Platelet composition and function in patients undergoing cardiopulmonary bypass for heart surgery

Haematologica

Volumn 81, Issue 2, 1996, Pages 116-120

  Bertolino, Giampiera ^a   Locatelli, Alessandro ^b   Noris, Patrizia ^a   Maurelli, Marco ^b   Ceriana, Piero ^b   Mazzini, Giuliano ^c   Spedini, Pierangelo ^a   Belletti, Simona ^a   Balduini, Carlo L ^a,b  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

^c Ctro di Stud per l'Istochimica   (Italy)

Author keywords

Cardiopulmonary by pass; Heart surgery; Platelets

Indexed keywords

APROTININ; TRAYSLOL; UNCLASSIFIED DRUG;

ARTICLE; BLOOD FILTER; CARDIOPULMONARY BYPASS; CELL DAMAGE; CELL PROTECTION; CLINICAL ARTICLE; CLINICAL TRIAL; CORONARY ARTERY BYPASS SURGERY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; HEART VALVE PROSTHESIS; HEART VALVE REPLACEMENT; HUMAN; OXYGENATOR; PREOPERATIVE EVALUATION; PROTEIN DEGRADATION; REOPERATION; RISK ASSESSMENT; THROMBOCYTE AGGLUTINATION; THROMBOCYTE AGGREGATION; THROMBOCYTE COUNT;

APROTININ; BLOOD PLATELETS; CARDIAC SURGICAL PROCEDURES; CARDIOPULMONARY BYPASS; DOUBLE-BLIND METHOD; HUMANS; SERINE PROTEINASE INHIBITORS;

EID: 0030323794     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Giordano GF, Giordano GF Jr, River SL, et al. Determinants of homologous blood usage utilizing autologous platelet-rich plasma in cardiac operations. Ann Thorac Surg 1989; 47:897-902.
2. Dechavanne M, French M, Pages J, et al. Significant reduction in the binding of a monoclonal antibody (LYP 18) directed against the IIb/IIIa glycoprotein complex to platelets of patients having undergone extracorporeal circulation. Thromb Haemost 1987; 57:106-9.
3. Woodman RC, Harker LA. Bleeding complications associated with cardiopulmonary bypass. Blood 1990; 76:1680-97.
4. van Oeveren W, Harder MP, Roozendaal KJ, Eijsman L, Wildevuur CRH. Aprotinin protects platelets against the initial effect of cardiopulmonary bypass. J Thorac Cardiovasc Surg 1990;99;788-97.
5. Rinder CS, Mathew JP, Rinder HM, Bonan J, Ault KA, Smith BR. Modulation of platelet surface adhesion receptors during cardiopulmonary bypass. Anesthesiology 1991; 75:563-70.
6. Huang H, Ding W, Su Z, Zhang W. Mechanism of the preserving effect of aprotinin on platelet function and its use in cardiac surgery. J Thorac Cardiovasc Surg 1993; 106:11-8.
7. Bertolino G, Noris P, Previtali M, et al. Platelet function after in vivo and in vitro treatment with thrombolytic agents. Am J Cardiol 1992; 69:457-61.
8. Grignani G, Zucchella M, Brocchieri A, Saporiti A. Current concepts in coronary thrombolysis. Haematologica 1994; 79:475-82.
9. Westaby S. Aprotinin in perspective. Ann Thorac Surg 1993; 55:1033-41.
10. Orchard MA, Goodchild CS, Prentice CRM, et al. Aprotinin reduces cardiopulmonary bypass-induced blood loss and inhibits fibrinolysis without influencing platelets. Br J Haematol 1993; 85:533-41.
11. Born GVR. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194:927-9.
12. Balduini CL, Bertolino G, Noris P, et al. Defect of platelet aggregation and adhesion induced by autoantibodies against platelet glycoprotein IIIa. Thromb Haemost 1992; 68:208-13.
13. Laemmli UK. Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 1970; 227:680-5.
14. Lowry OH, Rosenbrough NJ, Farr AL, Randal RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1970; 193:265-75.
15. Brister SJ, Ofosu FA, Buchanan MR. Thrombin generation during cardiac surgery: is heparin the ideal anticoagulant? Thromb Haemost 1993; 70:259-62.
16. Boisclair MD, Lane DA, Philippou H, Sheikh S, Hunt B. Thrombin production, inactivation and expression during open heart surgery measured by assay for activation fragments including a new ELISA for prothrombin fragments F1+2. Thromb Haemost 1993; 70:253-8.
17. Kestin AS, Valeri CR, Khuri SF, et al. The platelet function defect of cardiopulmonary bypass. Blood 1993; 82:107-17.